» Articles » PMID: 37288170

A Study Based on Network Pharmacology Decoding the Multi-Target Mechanism of Duhuo Jisheng Decoction for the Treatment of Intervertebral Disc Degeneration

Overview
Specialty Biology
Date 2023 Jun 8
PMID 37288170
Authors
Affiliations
Soon will be listed here.
Abstract

Intervertebral disc degeneration (IDD) poses a grim public health impact. Duhuo Jisheng Decoction (DJD), a traditional Chinese medicine formula, has recently received significant attention for its efficacy and safety in treating IDD. However, the pathological processes of IDD in which DJD interferes and molecular mechanism involved are poorly understood, which brings difficulties to the clinical practice of DJD for the treatment of IDD. This study systematically investigated the underlying mechanism of DJD treatment of IDD. Network pharmacology approaches were employed, integrating molecular docking and random walk with restart (RWR) algorithm, to identify key compounds and targets for DJD in the treatment of IDD. Bioinformatics approaches were used to further explore the biological insights in DJD treatment of IDD. The analysis identifies AKT1, PIK3R1, CHUK, ALB, TP53, MYC, NR3C1, IL1B, ERBB2, CAV1, CTNNB1, AR, IGF2, and ESR1 as key targets. Responses to mechanical stress, oxidative stress, cellular inflammatory responses, autophagy, and apoptosis are identified as the critical biological processes involved in DJD treatment of IDD. The regulation of DJD targets in extracellular matrix components, ion channel regulation, transcriptional regulation, synthesis and metabolic regulation of reactive oxygen products in the respiratory chain and mitochondria, fatty acid oxidation, the metabolism of Arachidonic acid, and regulation of Rho and Ras protein activation are found to be potential mechanisms in disc tissue response to mechanical stress and oxidative stress. MAPK, PI3K/AKT, and NF-B signaling pathways are identified as vital signaling pathways for DJD to treat IDD. Quercetin and Kaempferol are assigned a central position in the treatment of IDD. This study contributes to a more comprehensive understanding of the mechanism of DJD in treating IDD. It provides a reference for applying natural products to delay the pathological process of IDD.

Citing Articles

Targeting nucleus pulposus cell death in the treatment of intervertebral disc degeneration.

Sun H, Guo J, Xiong Z, Zhuang Y, Ning X, Liu M JOR Spine. 2024; 7(4):e70011.

PMID: 39703198 PMC: 11655182. DOI: 10.1002/jsp2.70011.

References
1.
Liu L, Xu L, Wang S, Wang L, Wang X, Xu H . Confirmation of inhibitingTLR4/MyD88/NF-κB Signalling Pathway by Duhuo Jisheng Decoction on Osteoarthritis: A Network Pharmacology Approach-Integrated Experimental Study. Front Pharmacol. 2022; 12:784822. PMC: 8818874. DOI: 10.3389/fphar.2021.784822. View

2.
Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M . GeneCards Version 3: the human gene integrator. Database (Oxford). 2010; 2010:baq020. PMC: 2938269. DOI: 10.1093/database/baq020. View

3.
Pettersen E, Goddard T, Huang C, Couch G, Greenblatt D, Meng E . UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem. 2004; 25(13):1605-12. DOI: 10.1002/jcc.20084. View

4.
McKay L, White J . The AMPK/p27 Pathway as a Novel Target to Promote Autophagy and Resilience in Aged Cells. Cells. 2021; 10(6). PMC: 8229180. DOI: 10.3390/cells10061430. View

5.
Zeng P, Su H, Ye C, Qiu S, Tian Q . Therapeutic Mechanism and Key Alkaloids of in Alzheimer's Disease From the Perspective of Pathophysiological Processes. Front Pharmacol. 2022; 12:806984. PMC: 8715940. DOI: 10.3389/fphar.2021.806984. View